Anxo Pharmaceutical Co., Ltd. (TPEX:6677)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
20.10
-0.25 (-1.23%)
Mar 6, 2026, 12:22 PM CST

Anxo Pharmaceutical Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1,1371,3362,7081,4261,1851,376
Market Cap Growth
-19.27%-50.67%89.95%20.32%-13.90%-3.90%
Enterprise Value
1,6581,8373,4972,1941,9892,164
Last Close Price
20.3524.0048.1128.2323.4627.25
PE Ratio
--123.88-61.6043.82
PS Ratio
1.291.492.881.651.441.59
PB Ratio
1.021.172.251.721.421.70
P/TBV Ratio
1.191.372.582.091.712.05
P/FCF Ratio
39.6419.18-25.1627.2331.35
P/OCF Ratio
17.2711.93-20.0015.1222.98
EV/Sales Ratio
1.882.053.722.532.412.50
EV/EBITDA Ratio
61.14448.0230.9232.0119.1017.14
EV/EBIT Ratio
--65.59368.9849.6137.97
EV/FCF Ratio
57.8026.38-38.7145.7349.29
Debt / Equity Ratio
0.640.640.661.071.061.10
Debt / EBITDA Ratio
26.5138.136.2111.187.746.52
Debt / FCF Ratio
25.0610.44-15.6520.2820.25
Net Debt / Equity Ratio
0.360.320.340.780.800.84
Net Debt / EBITDA Ratio
32.5089.143.569.426.425.40
Net Debt / FCF Ratio
14.105.25-6.6611.3915.3615.52
Asset Turnover
0.420.410.450.450.430.45
Inventory Turnover
2.022.092.062.221.952.13
Quick Ratio
1.061.151.330.890.920.88
Current Ratio
1.681.752.011.391.491.51
Return on Equity (ROE)
-3.79%-4.62%3.03%-0.85%2.40%5.15%
Return on Assets (ROA)
-1.42%-1.64%1.59%0.19%1.31%1.86%
Return on Invested Capital (ROIC)
-3.15%-3.64%2.76%0.40%2.17%3.01%
Return on Capital Employed (ROCE)
-3.10%-3.50%3.10%0.40%2.80%3.90%
Earnings Yield
-3.72%-4.28%0.81%-0.88%1.62%2.28%
FCF Yield
2.52%5.21%-2.23%3.98%3.67%3.19%
Dividend Yield
--0.83%---
Payout Ratio
-----36.52%
Buyback Yield / Dilution
-2.25%-8.00%-7.11%0.66%-0.88%-7.05%
Total Shareholder Return
-2.25%-8.00%-6.28%0.66%-0.88%-7.05%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.